Cutera (CUTR) engages in the research, design, development, manufacture, marketing, sales, and service of laser and light-based systems for aesthetic and podiatric applications worldwide.
It offers a range of non-invasive laser and intense pulsed light products for use in the treatment of cosmetic vascular conditions, pigmented lesions, skin rejuvenation, hair removal, acne, scar revision, and onychomycosis (nail fungus). The company primarily serves dermatologists, plastic surgeons, gynecologists, family practitioners, primary care physicians, physicians offering aesthetic treatments in non-medical offices, and other qualified practitioners.
We are now hearing rumors of good news for this company. One of the rumors states that this stock will be named by the leading stock advisory service as one of its "top picks." This service is widely followed by mutual funds and institutional money managers. These investors have portfolios that mimic recommendations of this service. Their naming of the stock should lead to additional demand for the shares.
52-Week Trading Range: $6.33 - $13.16
Entry Point: $12.47
Stop Loss: $11.85
Target Price: $13.72
We are closing CUTR at $12.92 after the issue failed to gain 10% in 30-days. We had a return of 3.6%.